Skip to main content
Top
Published in: Diabetologia 7/2015

Open Access 01-07-2015 | Article

Higher glucose, insulin and insulin resistance (HOMA-IR) in childhood predict adverse cardiovascular risk in early adulthood: the Pune Children’s Study

Authors: Chittaranjan S. Yajnik, Prachi A. Katre, Suyog M. Joshi, Kalyanaraman Kumaran, Dattatray S. Bhat, Himangi G. Lubree, Nilam Memane, Arun S. Kinare, Anand N. Pandit, Sheila A. Bhave, Ashish Bavdekar, Caroline H. D. Fall

Published in: Diabetologia | Issue 7/2015

Login to get access

Abstract

Aims/hypothesis

The Pune Children’s Study aimed to test whether glucose and insulin measurements in childhood predict cardiovascular risk factors in young adulthood.

Methods

We followed up 357 participants (75% follow-up) at 21 years of age who had undergone detailed measurements at 8 years of age (glucose, insulin, HOMA-IR and other indices). Oral glucose tolerance, anthropometry, plasma lipids, BP, carotid intima–media thickness (IMT) and arterial pulse wave velocity (PWV) were measured at 21 years.

Results

Higher fasting glucose, insulin and HOMA-IR at 8 years predicted higher glucose, insulin, HOMA-IR, BP, lipids and IMT at 21 years. A 1 SD change in 8 year variables was associated with a 0.10–0.27 SD change at 21 years independently of obesity/adiposity at 8 years of age. A greater rise in glucose–insulin variables between 8 and 21 years was associated with higher cardiovascular risk factors, including PWV. Participants whose HOMA-IR measurement remained in the highest quartile (n = 31) had a more adverse cardiovascular risk profile compared with those whose HOMA-IR measurement remained in the lowest quartile (n = 28).

Conclusions/interpretation

Prepubertal glucose–insulin metabolism is associated with adult cardiovascular risk and markers of atherosclerosis. Our results support interventions to improve glucose–insulin metabolism in childhood to reduce cardiovascular risk in later life.
Appendix
Available only for authorised users
Literature
2.
go back to reference Yajnik CS, Fall CH, Vaidya U (1995) Fetal growth and glucose and insulin metabolism in four year-old Indian children. Diabet Med 12:330–336PubMedCrossRef Yajnik CS, Fall CH, Vaidya U (1995) Fetal growth and glucose and insulin metabolism in four year-old Indian children. Diabet Med 12:330–336PubMedCrossRef
3.
go back to reference Rao S, Yajnik CS, Kanade A (2001) Intake of micronutrient-rich foods in rural Indian mothers is associated with the size of their babies at birth: Pune Maternal Nutrition Study. J Nutr 131:1217–1224PubMed Rao S, Yajnik CS, Kanade A (2001) Intake of micronutrient-rich foods in rural Indian mothers is associated with the size of their babies at birth: Pune Maternal Nutrition Study. J Nutr 131:1217–1224PubMed
4.
go back to reference Inskip HM, Godfrey KM, Robinson SM et al (2006) Cohort profile: the Southampton Women's Survey. Int J Epidemiol 35:42–48PubMedCrossRef Inskip HM, Godfrey KM, Robinson SM et al (2006) Cohort profile: the Southampton Women's Survey. Int J Epidemiol 35:42–48PubMedCrossRef
5.
go back to reference Richter LM, Victora CG, Hallal PC et al (2012) Cohort profile: the consortium of health-orientated research in transitioning societies. Int J Epidemiol 41:621–626PubMedCentralPubMedCrossRef Richter LM, Victora CG, Hallal PC et al (2012) Cohort profile: the consortium of health-orientated research in transitioning societies. Int J Epidemiol 41:621–626PubMedCentralPubMedCrossRef
6.
go back to reference Bavdekar A, Yajnik CS, Fall CH et al (1999) Insulin resistance syndrome in 8 year-old Indian children: small at birth, big at 8 years, or both? Diabetes 48:2422–2429PubMedCrossRef Bavdekar A, Yajnik CS, Fall CH et al (1999) Insulin resistance syndrome in 8 year-old Indian children: small at birth, big at 8 years, or both? Diabetes 48:2422–2429PubMedCrossRef
7.
go back to reference Krishnaveni GV, Veena SR, Wills AK, Hill JC, Katat SC, Fall CH (2010) Adiposity, insulin resistance and cardiovascular risk factors in 9-10 year-old Indian children: relationships with birth size and postnatal growth. J Dev Orig Health Dis 1:403–411PubMedCentralPubMedCrossRef Krishnaveni GV, Veena SR, Wills AK, Hill JC, Katat SC, Fall CH (2010) Adiposity, insulin resistance and cardiovascular risk factors in 9-10 year-old Indian children: relationships with birth size and postnatal growth. J Dev Orig Health Dis 1:403–411PubMedCentralPubMedCrossRef
8.
go back to reference Welborn TA, Wearne K (1979) Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care 2:154–160PubMedCrossRef Welborn TA, Wearne K (1979) Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care 2:154–160PubMedCrossRef
9.
go back to reference Ducimetiere P, Eschwege E, Papoz L, Richard JL, Claude JR, Rosselin G (1980) Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia 19:205–210PubMedCrossRef Ducimetiere P, Eschwege E, Papoz L, Richard JL, Claude JR, Rosselin G (1980) Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia 19:205–210PubMedCrossRef
10.
go back to reference Pyorala K, Savolainen E, Kaukola S, Haapakoski J (1985) Plasma insulin as coronary heart disease risk factor: relationship to other risk factors and predictive value during 9½ year follow-up of the Helsinki Policemen Study population. Acta Med Scand Suppl 701:38–52PubMed Pyorala K, Savolainen E, Kaukola S, Haapakoski J (1985) Plasma insulin as coronary heart disease risk factor: relationship to other risk factors and predictive value during 9½ year follow-up of the Helsinki Policemen Study population. Acta Med Scand Suppl 701:38–52PubMed
11.
go back to reference American Diabetes Association (2014) Standards of medical care in diabetes—2014. Diabetes Care 37(Suppl 1):S14–S80CrossRef American Diabetes Association (2014) Standards of medical care in diabetes—2014. Diabetes Care 37(Suppl 1):S14–S80CrossRef
12.
go back to reference Alberti KG, Zimmet P, Shaw J (2006) Metabolic syndrome—a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med 23:469–480PubMedCrossRef Alberti KG, Zimmet P, Shaw J (2006) Metabolic syndrome—a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med 23:469–480PubMedCrossRef
13.
go back to reference Gerstein HC, Bosch J, Dagenais GR et al (2012) Basal insulin and cardiovascular and other outcomes in dysglycaemia. N Engl J Med 367:319–328PubMedCrossRef Gerstein HC, Bosch J, Dagenais GR et al (2012) Basal insulin and cardiovascular and other outcomes in dysglycaemia. N Engl J Med 367:319–328PubMedCrossRef
15.
go back to reference Reaven GM (1988) Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37:1595–1607PubMedCrossRef Reaven GM (1988) Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37:1595–1607PubMedCrossRef
17.
go back to reference Jiang X, Srinivasan SR, Bao W, Berenson GS (1993) Association of fasting insulin with blood pressure in young individuals. The Bogalusa Heart Study. Arch Intern Med 153:323–328PubMedCrossRef Jiang X, Srinivasan SR, Bao W, Berenson GS (1993) Association of fasting insulin with blood pressure in young individuals. The Bogalusa Heart Study. Arch Intern Med 153:323–328PubMedCrossRef
18.
go back to reference Manolio TA, Savage PJ, Burke GL et al (1990) Association of fasting insulin with blood pressure and lipids in young adults. The CARDIA study. Arteriosclerosis 10:430–436PubMedCrossRef Manolio TA, Savage PJ, Burke GL et al (1990) Association of fasting insulin with blood pressure and lipids in young adults. The CARDIA study. Arteriosclerosis 10:430–436PubMedCrossRef
19.
go back to reference Juhola J, Magnussen CG, Viikari JS et al (2011) Tracking of serum lipid levels, blood pressure, and body mass index from childhood to adulthood: the Cardiovascular Risk in Young Finns Study. J Pediatr 159:584–590PubMedCrossRef Juhola J, Magnussen CG, Viikari JS et al (2011) Tracking of serum lipid levels, blood pressure, and body mass index from childhood to adulthood: the Cardiovascular Risk in Young Finns Study. J Pediatr 159:584–590PubMedCrossRef
20.
go back to reference Twisk JW, Kemper HC, van Mechelen W, Post GB (1997) Tracking of risk factors for coronary heart disease over a 14 year period: a comparison between lifestyle and biologic risk factors with data from the Amsterdam Growth and Health Study. Am J Epidemiol 145:888–898PubMedCrossRef Twisk JW, Kemper HC, van Mechelen W, Post GB (1997) Tracking of risk factors for coronary heart disease over a 14 year period: a comparison between lifestyle and biologic risk factors with data from the Amsterdam Growth and Health Study. Am J Epidemiol 145:888–898PubMedCrossRef
21.
go back to reference Akerblom HK, Viikari J, Raitakari OT, Uhari M (1999) Cardiovascular Risk in Young Finns Study: general outline and recent developments. Ann Med 31(Suppl 1):45S–54S Akerblom HK, Viikari J, Raitakari OT, Uhari M (1999) Cardiovascular Risk in Young Finns Study: general outline and recent developments. Ann Med 31(Suppl 1):45S–54S
22.
go back to reference Joshi SM, Katre PA, Kumaran K et al (2014) Tracking of cardiovascular risk factors from childhood to young adulthood—the Pune Children's Study. Int J Cardiol 175:176–178PubMedCentralPubMedCrossRef Joshi SM, Katre PA, Kumaran K et al (2014) Tracking of cardiovascular risk factors from childhood to young adulthood—the Pune Children's Study. Int J Cardiol 175:176–178PubMedCentralPubMedCrossRef
23.
go back to reference Nguyen QM, Srinivasan SR, Xu JH, Chen W, Kieltyka L, Berenson GS (2010) Utility of childhood glucose homeostasis variables in predicting adult diabetes and related cardiometabolic risk factors: the Bogalusa Heart Study. Diabetes Care 33:670–675PubMedCentralPubMedCrossRef Nguyen QM, Srinivasan SR, Xu JH, Chen W, Kieltyka L, Berenson GS (2010) Utility of childhood glucose homeostasis variables in predicting adult diabetes and related cardiometabolic risk factors: the Bogalusa Heart Study. Diabetes Care 33:670–675PubMedCentralPubMedCrossRef
24.
go back to reference Bao W, Srinivasan SR, Berenson GS (1996) Persistent elevation of plasma insulin levels is associated with increased cardiovascular risk in children and young adults. The Bogalusa Heart Study. Circulation 93:54–59PubMedCrossRef Bao W, Srinivasan SR, Berenson GS (1996) Persistent elevation of plasma insulin levels is associated with increased cardiovascular risk in children and young adults. The Bogalusa Heart Study. Circulation 93:54–59PubMedCrossRef
25.
go back to reference Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE (2014) Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract 103:137–149PubMedCrossRef Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE (2014) Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract 103:137–149PubMedCrossRef
26.
go back to reference Ramachandran A, Snehalatha C, Kapur A et al (2001) High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey. Diabetologia 44:1094–1101PubMedCrossRef Ramachandran A, Snehalatha C, Kapur A et al (2001) High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey. Diabetologia 44:1094–1101PubMedCrossRef
27.
go back to reference Seshiah V, Diabetes in Pregnancy Study Group India (2010) Fifth National Conference of Diabetes in Pregnancy Study Group, India. J Assoc Physicians India 58:329–330PubMed Seshiah V, Diabetes in Pregnancy Study Group India (2010) Fifth National Conference of Diabetes in Pregnancy Study Group, India. J Assoc Physicians India 58:329–330PubMed
28.
go back to reference McKeigue PM, Shah B, Marmot MG (1991) Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 337:382–386PubMedCrossRef McKeigue PM, Shah B, Marmot MG (1991) Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 337:382–386PubMedCrossRef
29.
go back to reference Burke JP, Hale DE, Hazuda HP, Stern MP (1999) A quantitative scale of acanthosis nigricans. Diabetes Care 22:1655–1659PubMedCrossRef Burke JP, Hale DE, Hazuda HP, Stern MP (1999) A quantitative scale of acanthosis nigricans. Diabetes Care 22:1655–1659PubMedCrossRef
30.
go back to reference Baldassarre D, Amato M, Bondioli A, Sirtori CR, Tremoli E (2000) Carotid artery intima–media thickness measured by ultrasonography in normal clinical practice correlates well with atherosclerosis risk factors. Stroke 31:2426–2430PubMedCrossRef Baldassarre D, Amato M, Bondioli A, Sirtori CR, Tremoli E (2000) Carotid artery intima–media thickness measured by ultrasonography in normal clinical practice correlates well with atherosclerosis risk factors. Stroke 31:2426–2430PubMedCrossRef
31.
go back to reference Naidu MU, Reddy BM, Yashmaina S, Patnaik AN, Rani PU (2005) Validity and reproducibility of arterial pulse wave velocity measurement using new device with oscillometric technique: a pilot study. Biomed Eng Online 4:49PubMedCentralPubMedCrossRef Naidu MU, Reddy BM, Yashmaina S, Patnaik AN, Rani PU (2005) Validity and reproducibility of arterial pulse wave velocity measurement using new device with oscillometric technique: a pilot study. Biomed Eng Online 4:49PubMedCentralPubMedCrossRef
32.
go back to reference Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419PubMedCrossRef Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419PubMedCrossRef
33.
go back to reference Wareham NJ, Phillips DI, Byrne CD, Hales CN (1995) The 30 minute insulin incremental response in an oral glucose tolerance test as a measure of insulin secretion. Diabet Med 12:931PubMedCrossRef Wareham NJ, Phillips DI, Byrne CD, Hales CN (1995) The 30 minute insulin incremental response in an oral glucose tolerance test as a measure of insulin secretion. Diabet Med 12:931PubMedCrossRef
34.
go back to reference DeFronzo RA, Matsuda M (2010) Reduced time points to calculate the composite index. Diabetes Care 33, e93PubMedCrossRef DeFronzo RA, Matsuda M (2010) Reduced time points to calculate the composite index. Diabetes Care 33, e93PubMedCrossRef
35.
36.
go back to reference National Cholesterol Education Program Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), 2002. (Publication no. NIH 02:5215). National Institutes of Health, Bethesda, MD National Cholesterol Education Program Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), 2002. (Publication no. NIH 02:5215). National Institutes of Health, Bethesda, MD
37.
go back to reference Willett WC, Howe GR, Kushi LH (1997) Adjustment for total energy intake in epidemiological studies. Am J Clin Nutr 65(Suppl 4):1220S–1228SPubMed Willett WC, Howe GR, Kushi LH (1997) Adjustment for total energy intake in epidemiological studies. Am J Clin Nutr 65(Suppl 4):1220S–1228SPubMed
38.
39.
go back to reference Li C, Ford ES, Zhao G, Mokdad AH (2009) Prevalence of pre-diabetes and its association with clustering of cardiometabolic risk factors and hyperinsulinemia among U.S. adolescents: National Health and Nutrition Examination Survey 2005-2006. Diabetes Care 32:342–347PubMedCentralPubMedCrossRef Li C, Ford ES, Zhao G, Mokdad AH (2009) Prevalence of pre-diabetes and its association with clustering of cardiometabolic risk factors and hyperinsulinemia among U.S. adolescents: National Health and Nutrition Examination Survey 2005-2006. Diabetes Care 32:342–347PubMedCentralPubMedCrossRef
40.
go back to reference Goran MI, Lane C, Toledo-Corral C, Weigensberg MJ (2008) Persistence of pre-diabetes in overweight and obese Hispanic children: association with progressive insulin resistance, poor beta-cell function, and increasing visceral fat. Diabetes 57:3007–3012PubMedCentralPubMedCrossRef Goran MI, Lane C, Toledo-Corral C, Weigensberg MJ (2008) Persistence of pre-diabetes in overweight and obese Hispanic children: association with progressive insulin resistance, poor beta-cell function, and increasing visceral fat. Diabetes 57:3007–3012PubMedCentralPubMedCrossRef
41.
go back to reference Sinaiko AR, Steinberger J, Moran A, Hong CP, Prineas RJ, Jacobs DR Jr (2006) Influence of insulin resistance and body mass index at age 13 on systolic blood pressure, triglycerides, and high-density lipoprotein cholesterol at age 19. Hypertension 48:730–736PubMedCrossRef Sinaiko AR, Steinberger J, Moran A, Hong CP, Prineas RJ, Jacobs DR Jr (2006) Influence of insulin resistance and body mass index at age 13 on systolic blood pressure, triglycerides, and high-density lipoprotein cholesterol at age 19. Hypertension 48:730–736PubMedCrossRef
42.
go back to reference Brownlee M (2005) The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54:1615–1625PubMedCrossRef Brownlee M (2005) The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54:1615–1625PubMedCrossRef
43.
go back to reference DeFronzo RA, Ferrannini E (1991) Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14:173–194PubMedCrossRef DeFronzo RA, Ferrannini E (1991) Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14:173–194PubMedCrossRef
44.
go back to reference Reddy MA, Zhang E, Natarajan R (2015) Epigenetic mechanisms in diabetic complications and metabolic memory. Diabetologia 58:443–455PubMedCrossRef Reddy MA, Zhang E, Natarajan R (2015) Epigenetic mechanisms in diabetic complications and metabolic memory. Diabetologia 58:443–455PubMedCrossRef
45.
go back to reference Goldin A, Beckman JA, Schmidt AM, Creager MA (2006) Advanced glycation end products. Sparking the development of diabetic vascular injury. Circulation 114:597–605PubMedCrossRef Goldin A, Beckman JA, Schmidt AM, Creager MA (2006) Advanced glycation end products. Sparking the development of diabetic vascular injury. Circulation 114:597–605PubMedCrossRef
46.
go back to reference Dunkley AJ, Bodicoat DH, Greaves CJ et al (2014) Diabetes prevention in the real world: effectiveness of pragmatic lifestyle interventions for the prevention of type 2 diabetes and of the impact of adherence to guideline recommendations: a systematic review and meta-analysis. Diabetes Care 37:922–933PubMedCrossRef Dunkley AJ, Bodicoat DH, Greaves CJ et al (2014) Diabetes prevention in the real world: effectiveness of pragmatic lifestyle interventions for the prevention of type 2 diabetes and of the impact of adherence to guideline recommendations: a systematic review and meta-analysis. Diabetes Care 37:922–933PubMedCrossRef
47.
go back to reference Gerstein HC, Yusuf S, Bosch J et al (2006) Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet 368:1096–1105PubMedCrossRef Gerstein HC, Yusuf S, Bosch J et al (2006) Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet 368:1096–1105PubMedCrossRef
48.
go back to reference Prentice P, Viner RM (2013) Pubertal timing and adult obesity and cardiometabolic risk in women and men: a systematic review and meta-analysis. Int J Obes 37:1036–1043CrossRef Prentice P, Viner RM (2013) Pubertal timing and adult obesity and cardiometabolic risk in women and men: a systematic review and meta-analysis. Int J Obes 37:1036–1043CrossRef
49.
go back to reference Taylor RW, McAuley KA, Barbezat W, Farmer VL, Williams SM, Mann JI (2008) Two year follow-up of an obesity prevention initiative in children: the APPLE project. Am J Clin Nutr 88:1371–1377PubMed Taylor RW, McAuley KA, Barbezat W, Farmer VL, Williams SM, Mann JI (2008) Two year follow-up of an obesity prevention initiative in children: the APPLE project. Am J Clin Nutr 88:1371–1377PubMed
50.
go back to reference Waters E, de Silva-Sanigorski A, Hall BJ, et al (2011) Interventions for preventing obesity in children. Cochrane Database Syst Rev, Issue 12, Art no.: CD001871. doi: 10.1002/14651858. CD001871.pub3 Waters E, de Silva-Sanigorski A, Hall BJ, et al (2011) Interventions for preventing obesity in children. Cochrane Database Syst Rev, Issue 12, Art no.: CD001871. doi: 10.​1002/​14651858. CD001871.pub3
51.
go back to reference Campbell F, Conti G, Heckman JJ, Moon SH, Pinto R, Pungello E, Pan Y (2014) Early childhood investments substantially boost adult health. Science 343:1478–1485PubMedCentralPubMedCrossRef Campbell F, Conti G, Heckman JJ, Moon SH, Pinto R, Pungello E, Pan Y (2014) Early childhood investments substantially boost adult health. Science 343:1478–1485PubMedCentralPubMedCrossRef
Metadata
Title
Higher glucose, insulin and insulin resistance (HOMA-IR) in childhood predict adverse cardiovascular risk in early adulthood: the Pune Children’s Study
Authors
Chittaranjan S. Yajnik
Prachi A. Katre
Suyog M. Joshi
Kalyanaraman Kumaran
Dattatray S. Bhat
Himangi G. Lubree
Nilam Memane
Arun S. Kinare
Anand N. Pandit
Sheila A. Bhave
Ashish Bavdekar
Caroline H. D. Fall
Publication date
01-07-2015
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 7/2015
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-015-3602-z

Other articles of this Issue 7/2015

Diabetologia 7/2015 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.